Clinical Trial Update: Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating buprenorphine as an adjunct to outpatient induction onto Vivitrol for opioid-use disorder was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)
• buprenorphine (buprenorphine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Opioid-use Disorder | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2022-03-02